Rigel Pharmaceuticals RIGL Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rigel Pharmaceuticals's interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rigel Pharmaceuticals's interest income?
- Rigel Pharmaceuticals (RIGL) reported interest income of $1.21M in Q1 2026.
- How has Rigel Pharmaceuticals's interest income changed year-over-year?
- Rigel Pharmaceuticals's interest income increased by 103.9% year-over-year, from $591K to $1.21M.
- What is the long-term trend for Rigel Pharmaceuticals's interest income?
- Over 4 years (2021 to 2025), Rigel Pharmaceuticals's interest income has grown at a 197.5% compound annual growth rate (CAGR), from $47K to $3.68M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.